Dokumentenart: | Artikel | ||||
---|---|---|---|---|---|
Titel eines Journals oder einer Zeitschrift: | Archiv der Pharmazie | ||||
Verlag: | Wiley | ||||
Band: | 326 | ||||
Nummer des Zeitschriftenheftes oder des Kapitels: | 7 | ||||
Seitenbereich: | S. 405-413 | ||||
Datum: | 1993 | ||||
Zusätzliche Informationen (Öffentlich): | CAN 119:240909 1-3 Pharmacology 7440-06-4D (Platinum); 126735-37-3; 128413-03-6; 128413-11-6; 128413-12-7; 128413-13-8; 128524-04-9; 128524-12-9; 128524-13-0; 128524-14-1; 150390-74-2; 150447-55-5; 150448-26-3; 150520-05-1; 150520-06-2; 151037-67-1 Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (estrogenic activity of, mammary antitumor activity in relation to); 150412-97-8 Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (estrogenic activity of, structure in relation to) | ||||
Institutionen: | Chemie und Pharmazie > Institut für Pharmazie > Entpflichtete oder im Ruhestand befindliche Professoren > Prof. Schönenberger | ||||
Projekte: | SFB 234 | ||||
Identifikationsnummer: |
| ||||
Stichwörter / Keywords: | Conformation and Conformers (of hydroxyphenylethylenediamine sulfatoplatinum complexes) Molecular structure-biological activity relationship (estrogenic, of hydroxyphenylethylenediamine sulfatoplatinum complexes) Neoplasm inhibitors (mammary gland, hydroxyphenylethylenediamine sulfatoplatinum complexes as, estrogenic activity in, structure-activity relations of) Mammary gland (neoplasm, inhibitors, hydroxyphenylethylenediamine sulfatoplatinum complexes as, estrogenic activity in, structure-activity relations of) estrogenic platinum complex conformation | ||||
Dewey-Dezimal-Klassifikation: | 500 Naturwissenschaften und Mathematik > 540 Chemie | ||||
Status: | Veröffentlicht | ||||
Begutachtet: | Ja, diese Version wurde begutachtet | ||||
An der Universität Regensburg entstanden: | Ja | ||||
Dokumenten-ID: | 17698 |
Zusammenfassung
1,2-Bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamines with 2,6-Cl2, 2-F,6-Cl, 2-Cl,6-F, and 2,6-F2 substituents (meso-1 to meso-4, D,L-1 and D,L-4) and their sulfatoplatinum(II) complexes were tested in the immature mouse uterine wt. test. The only complex with marked estrogenic properties proved to be meso-1-PtSO4. Surprisingly its diamine ligand meso-1 was only marginally active. 1H-NMR ...
Zusammenfassung
1,2-Bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamines with 2,6-Cl2, 2-F,6-Cl, 2-Cl,6-F, and 2,6-F2 substituents (meso-1 to meso-4, D,L-1 and D,L-4) and their sulfatoplatinum(II) complexes were tested in the immature mouse uterine wt. test. The only complex with marked estrogenic properties proved to be meso-1-PtSO4. Surprisingly its diamine ligand meso-1 was only marginally active. 1H-NMR spectroscopic studies on the 1,2-diphenylethylenediamine ligand reveal that the 2,6-standing Cl-atoms in meso-1 (antiperiplanar Ph residues) hinder the rotation of the arom. rings, which results in very stable conformers with different O-O distances owing to the unsym. arrangement of the ring substituents. On transformation into the Pt(II) complex the conformations of meso-1 change (synclinal Ph residues) and a delta and l interconversion takes place already at physiol. temp. (37 DegC). This process is accompanied by a rotation of Ph rings, which is supposed to allow an optimal fit for the formation of hydrogen bridges to the estrogen receptor, resulting in a marked estrogenic activity. The other ligands and complexes are inactive presumably due to a diminished hydrophobic interaction with the estrogen receptor, resulting from their R,R/S,S-configuration or the reduced no. of Cl-atoms.
Metadaten zuletzt geändert: 24 Mai 2018 12:18